UBS raised the firm’s price target on McKesson (MCK) to $860 from $820 and keeps a Buy rating on the shares. The company’s strong cash flow conversion and ongoing ability to reinvest in new growth markets while divesting slowing or underperforming assets continues to generate improving return on invested capital, the analyst tells investors in a research note. RxTS appears to be the driver of near-term outperformance, which lifts the FY26 outlook, the firm says.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MCK:
- McKesson’s Strategic Initiatives and Financial Performance Drive Buy Rating and Positive Outlook
- McKesson’s Strong Growth Prospects and Strategic Positioning Drive Buy Rating
- Trump links Tylenol use to autism, AutoZone reports downbeat Q4: Morning Buzz
- Early notable gainers among liquid option names on September 23rd
- McKesson up 4% at $726.22 after positive pre-announcement ahead of Investor Day